PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97347673 |
Filing Date: 04/05/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97347673 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\973\476\97347673\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | ALN, Atopic dermatitis Leadership Network |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) blue and violet is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the stylized letters A L N appearing in blue. The stylized letter A has a blue wave design ending in a spray of rounded droplets on the right side of the wave with three of the droplets in the color violet and the rest of the droplets appearing in shades of the color blue appearing in the middle of the letter A and extending over the letter L. Centered below the letters A L N are the stylized words "Atopic dermatitis Leadership Network" appearing in blue. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 563 x 314 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | LEO Pharma A/S |
*MAILING ADDRESS | Industriparken 55 |
*CITY | Ballerup |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Denmark |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
2750 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | public limited company (plc) |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED | Denmark |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 016 |
*IDENTIFICATION | Newsletters, speaker communications, magazines, catalogues, posters, flyers, graphical prints, graphical presentations and reproductions |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 038 |
*IDENTIFICATION | Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | B. Brett Heavner |
ATTORNEY DOCKET NUMBER | 14894.0077 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Finnegan, Henderson, Farabow, Garrett & Dunner LLP |
STREET | 901 New York Avenue NW |
CITY | Washington |
STATE | District of Columbia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 20001 |
PHONE | 202-408-4000 |
FAX | 202-408-4400 |
EMAIL ADDRESS | docketing@finnegan.com |
OTHER APPOINTED ATTORNEY | all the other attorneys of Finnegan, Henderson, Farabow, Garrett & Dunner LLP |
CORRESPONDENCE INFORMATION | |
NAME | B. Brett Heavner |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | docketing@finnegan.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | travis.smith@finnegan.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 700 |
*TOTAL FEES PAID | 700 |
SIGNATURE INFORMATION | |
SIGNATURE | /Tom Friis-Mikkelsen/ |
SIGNATORY'S NAME | Tom Friis-Mikkelsen |
SIGNATORY'S POSITION | Senior Manager, Head of Trademarks, Designs and Domain Names |
SIGNATORY'S PHONE NUMBER | +45 41851762 |
DATE SIGNED | 04/01/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97347673 |
Filing Date: 04/05/2022 |
The applicant's current Correspondence Information: |
B. Brett Heavner |
PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): travis.smith@finnegan.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|